Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

8 May 2008 11:19

UBS AG (EPT)08 May 2008 FORM 38.5(b) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(b) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader UBS AG London BranchCompany dealt in Expro International Group PlcClass of relevant security to which the 10p Ordinarydealings being disclosed relate (Note 1)Date of dealing 07 MAY 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) Long Short Number (%) Number (%)(1) Relevant securities 470,454 0.43% 0 0.00%(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal 470,454 0.43% 0 0.00% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal (c) Rights to subscribe (Note 2)Class of relevant security: Details 3. DEALINGS (Note 3) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 4) SALE 712 1515 pence SALE 250 1515 SALE 265 1515 SALE 200 1515 SALE 4 1515 SALE 200 1515 SALE 904 1515 PURCHASE 64 1515 PURCHASE 80 1516 PURCHASE 3 1516 PURCHASE 677 1516 PURCHASE 400 1516 PURCHASE 99 1516 SALE 363 1516 SALE 99 1516 SALE 167 1516 PURCHASE 916 1517 SALE 143 1517 SALE 27 1517 SALE 200 1517 SALE 300 1517 PURCHASE 787 1517 PURCHASE 522 1517 SALE 146 1517 SALE 2285 1517 PURCHASE 329 1517 PURCHASE 49 1517 SALE 911 1517 PURCHASE 10 1517 PURCHASE 4940 1518 PURCHASE 2598 1518 PURCHASE 611 1518 PURCHASE 1039 1518 PURCHASE 648 1518 PURCHASE 663 1518 PURCHASE 436 1518 PURCHASE 911 1520 PURCHASE 95 1520 SALE 930 1520 SALE 95 1520 SALE 255 1520 SALE 200 1522 SALE 200 1522 PURCHASE 186 1522 SALE 200 1523 SALE 9 1523 SALE 100 1523 SALE 100 1523 SALE 600 1523 SALE 1000 1523 SALE 200 1523 SALE 816 1523 SALE 402 1523 PURCHASE 171 1524 SALE 862 1524 PURCHASE 271 1524 PURCHASE 2114 1524 PURCHASE 270 1524 SALE 232 1524 SALE 695 1524 SALE 200 1524 PURCHASE 100 1524 SALE 95 1525 PURCHASE 158 1525 PURCHASE 157 1525 SALE 264 1526 SALE 423 1526 SALE 200 1526 SALE 200 1526 SALE 415 1526 SALE 200 1526 SALE 529 1527 SALE 184 1528 TOTAL PURCHASES 19,304 TOTAL SALES 16,782 (b) Derivatives transactions (other than options)Product name, e.g Long/short (Note 5) Number of securities Price per unitCFD (Note 6) (Note 4) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/call purchasing, to which the European received peroption varying etc option etc. unit (Note relates 4) (Note 6) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unitoption (Note 4) (d) Other dealings (including new securities) (Note 3) Nature of transaction Details Price per unit (if applicable)(Note 7) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 38.5(b) attached? (Note 8) NO Date of disclosure 08 MAY 2008Contact name NIMISHA SACHDEVTelephone number 020 7567 8762Name of offeree/offeror with which connected Halliburton CompanyNature of connection (Note 9) CONNECTED ADVISER Notes The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of AGM
2nd Jun 20267:00 amRNSFinal Results
7th Jan 20267:00 amRNSTrading Update
30th Sep 20257:00 amRNSUnaudited Interim Results
30th Jun 20257:00 amRNSResult of AGM - Replacement
26th Jun 202511:44 amRNSResult of AGM
3rd Jun 20253:00 pmRNSNotice of AGM & Posting of Annual Report
3rd Jun 20257:00 amRNSFinal Results
2nd May 20259:58 amRNSNotice of Results
3rd Apr 20257:00 amRNS-RASU+GSV Summit, Launch of Titanic VR & ENGAGE 4.0
10th Feb 20257:00 amRNS-RENGAGE XR attending Leap 2025 with PwC Middle East
22nd Jan 20257:00 amRNS-RLaunch of Education Offering at Bett 2025
6th Jan 20257:00 amRNSPre-Close Trading Update
26th Sep 20243:51 pmRNSHolding(s) in Company
26th Sep 20243:50 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSUnaudited Interim Results
9th Aug 20247:00 amRNSAppointment of Sole Broker
6th Aug 20247:00 amRNSPre-Close Trading Update and Notice of Results
30th Jul 20245:32 pmRNSHolding(s) in Company
10th Jul 20248:59 amRNSHolding(s) in Company
27th Jun 20244:11 pmRNSHolding(s) in Company
27th Jun 20243:35 pmRNSResult of AGM
28th May 20247:22 amRNSNotice of AGM & Posting of Annual Report
28th May 20247:00 amRNSBoard and Committee Changes
23rd Apr 202412:53 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSFinal Results
28th Mar 20247:00 amRNSNotice of Results & Investor Presentation
13th Mar 20247:00 amRNSLaunch of School of AI
26th Feb 20247:00 amRNSTrading Update
23rd Feb 20247:00 amRNSHolding(s) in Company
20th Feb 20247:00 amRNSMajor Contract Wins
19th Dec 20237:00 amRNSTrading Update
8th Dec 20237:00 amRNSBoard Change
11th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSNotice of Investor Presentation
3rd Aug 20237:00 amRNSGrant of Options
1st Aug 20237:00 amRNSPre-Close Trading Update and Notice of Results
29th Jun 20232:23 pmRNSResult of AGM
7th Jun 20237:00 amRNSNotice of AGM
1st Jun 20237:00 amRNSLaunch of Lenovo’s new VR headset
23rd May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSInvestor Presentation
27th Apr 20237:00 amRNSTrading Update & Notice of Results
31st Mar 20237:00 amRNSFatboy Slim concert takes place in ENGAGE Link
21st Mar 20237:00 amRNSCancellation of Admission to Euronext Growth
17th Mar 20237:00 amRNSFatboy Slim set to perform in ENGAGE
8th Mar 20231:05 pmRNSTR-1: Notification of major holdings
7th Mar 20235:30 pmRNSTR-1: Notification of major holdings
7th Mar 20232:19 pmRNSTR-1: Notification of major holdings
6th Mar 20234:50 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.